Navigation Links
Study Finds Lifeclinic Self-Testing Health Stations in Workplace Help Reduce Hypertension and Obesity
Date:2/10/2009

A new study finds that Lifeclinic automated self-testing health stations in the workplace are a valuable tool for employees and employers in the management of hypertension and obesity. Results of the study appear in the January 2009 issue of Postgraduate Medicine, a peer-reviewed medical journal.

Burtonsville, MD (PRWEB) February 10, 2009 -- A new study finds that Lifeclinic automated self-testing health stations in the workplace are a valuable tool for employees and employers in the management of hypertension and obesity.

Results of the study appear in the January 2009 issue of Postgraduate Medicine, a peer-reviewed medical journal.

The study analyzed blood pressure and weight data collected over an 18 month period from 18 Lifeclinic LC500 health stations installed in 13 workplace locations of a company with approximately 20,000 employees.

The study found that:

  • Over 21% of the employees voluntarily used worksite health stations to measure their blood pressure or weight.
  • Worksite health stations identified 27% as hypertensive, 40% as pre-hypertensive, 38% as obese, and 35% as overweight.
  • Approximately half of the employees with hypertension and 10% of the employees with obesity successfully reduced their health risks.

"Worksite health stations provide cost-effective tools to fight the hypertension and obesity epidemic, which hurts employee health and productivity," said John T. Kelly, MD, Lifeclinic's Chief Medical Officer. "Worksite health stations increase employee awareness of health risks, encourage behavior change to reduce health risks, support effective health promotion programs, improve employee health, and enhance productivity."

More than one thousand employers have installed several thousand Lifeclinic self-testing health stations at worksites. The Lifeclinic LC500 provides automated measurements of blood pressure, pulse, weight, body fat, and BMI. Peripheral input ports interface with various personal health devices, including pedometers. The LC500 is Internet-ready for secure, HIPAA-compliant, connection to health and wellness tools. Additional information about the Lifeclinic LC500 is available at www.lifeclinic.com.

"Worksite health stations integrate health promotion into the worksite and its culture, reach employees who normally would not be engaged in health improvement, and support health and productivity improvement," said Dr. Kelly.

About Lifeclinic International, Inc.:
Lifeclinic is the world's largest supplier of commercial, automated, blood pressure monitors and health stations. Lifeclinic blood pressure monitors can be found in over 30,000 pharmacies and 5,000 worksites, medical clinics and health clubs worldwide, performing 500 million blood pressure measurements annually. Lifeclinic blood pressure machines, health stations and management systems encourage individuals to take an active role in their healthcare and provide corporate management with tools to help reduce costs while improving the health of individual employees.

###

Read the full story at http://www.prweb.com/releases/bloodpressure/machines/prweb2003674.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Most seniors have drug coverage, study shows
2. NADP Study Reports Dramatic Increase in Value of Dental Benefits
3. First brain study reveals benefits of exercise on quitting smoking
4. Mediterranean Diet Aids the Aging Brain: Study
5. Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study
6. HealthLeaders-InterStudy Offers District Survival Kit to Arm Pharmaceutical Sales Teams With Local-Level Managed Care Market Intelligence
7. New Research Study in Houston, Texas Seeks Improved Quality of Life for People in the Future with Schizophrenia
8. Kids and Their Families Are Hit Hardest During Flu Season, According to Thomson Reuters Study
9. Prism Pharmaceuticals Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology
10. Anti-HIV gel shows promise in large-scale study in women
11. Study questions effectiveness of $80 million per year brain exercise products industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of ... (ALCA) to conduct a survey that takes a closer look at cases of TBI ... prevalence and causes of TBI among the aging population, and identifies the challenges associated ...
(Date:2/10/2016)... ... February 10, 2016 , ... Gout is like no other ... that is often severe, with intense swelling and redness. It is triggered by the ... but older adults are the most susceptible, according to the February 2016 issue of ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The Association for ... speaker Jan Fox will serve as keynote speaker at the organization’s 2016 Spring ... tools to more effectively communicate with their own organizational staff and leadership. ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... it will attend the Ohio Safety Congress and Expo event March 9-11, 2016. ... the Greater Columbus Convention Center. , As the longest running and largest ...
(Date:2/10/2016)... Middleboro, MA (PRWEB) , ... February 10, 2016 ... ... of their revolutionary, biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns ... to provide a solution that ensures the integrity of biological samples while operating ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 10, 2016 ... Analyzers (Liquid & Gas), and Spectroscopy Market by Industry (Oil ... Beverage, Pulp & Paper, Metal & Mining, and Others), ... MarketsandMarkets, the global market is expected to grow to ... of 8.6% between 2015 and 2020. Browse ...
(Date:2/10/2016)... SEATTLE , Feb. 10, 2016  Resolve ... potentially transformative new approaches to the treatment of ... completion of a multiple ascending dose study in ... lead compound RSLV-132. --> ... double-blind, placebo-controlled multiple ascending dose study of RSLV-132 ...
(Date:2/10/2016)... , Feb. 10, 2016 Urologix, the market ... treatment of Benign Prostatic Hyperplasia (BPH), announces new private ... Keswani , a medical device industry veteran of more ... Limited Liability Company.  Plymouth, Minn. ... lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, will continue ...
Breaking Medicine Technology: